1. Executive Summary
2. Market Definition and Scope
3. Market Opportunity
4. Competitive Benchmarking (Financial and Market)
5. Company Profile on Following Parameters
6. Profiles on Following Companies
6.1. Abbott Laboratories
6.2. Invacare Corporation
6.3. Johnson & Johnson
6.4. 3M
6.2. Philips
List of Figures
CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for pesticide market
Figure 3.2: Global pesticide industry annual trend 2006-2011 (US $B)
Figure 3.3: Global pesticide industry regional trend 2006-2011 (US $B)
Figure 3.4: Global pesticide industry regional trend 2006-2011 (%)
Figure 3.5: Global pesticide industry segment trend 2006-2011 (US $B)
Figure 3.6: Global pesticide industry segment trend 2006-2011 (%)
Figure 3.7: Global pesticide industry opportunity by region
Figure 3.8: Global pesticide industry opportunity by segment
CHAPTER 4.Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five pesticide companies – financial benchmarking
Figure 4.2: Global top five pesticide companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis
Figure 4.7: 2011 Market share analysis
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011
Figure 4.10: Market value North America (US $B)
Figure 4.11: Market value Europe (US $B)
Figure 4.12: Market value Asia Pacific (US $B)
Figure 4.13: Market value Row: (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $M)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
CHAPTER 5. Company Profile of Abbott Laboratories
Figure 5.1: Abbott Laboratories revenue by business structure 2011
Figure 5.2: Lucintel Triad – Abbott Laboratories
Figure 5.3: Financial benchmarking Abbott Laboratories against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of Abbott Laboratories against Top Five best
Figure 5.5: Global industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 5.6: Global market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.9: APAC industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.12: European market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.15: Abbott Laboratories productivity: 2007-2011 in (US $B)
Figure 5.16: Abbott Laboratories fixed asset value: 2007-2011 in (US $B)
Figure 5.17: Strategic execution
CHAPTER 6. Company Profile of Invacare Corporation
Figure 6.1: Invacare Corporation. revenue by business structure 2011
Figure 6.2: Lucintel triad - Invacare Corporation
Figure 6.3: Financial benchmarking of Invacare Corporation. against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of Invacare Corporation against Top five best
Figure 6.5: Global industry revenue trend Vs Invacare Corporation (2007-2011) in (US $B)
Figure 6.6: Global market share trend for Invacare Corporation. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Invacare Corporation (2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.12: European market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.15: Invacare Corporation productivity: 2007-2011 in (US $B)
Figure 6.16: Invacare Corporation fixed asset value: 2007-2011 in (US $B)
Figure 6.17: Strategic execution
CHAPTER 7. Company Profile of Johnson & Johnson
Figure 7.1: Johnson & Johnson revenue by business structure 2011
Figure 7.2: Lucintel triad – Johnson & Johnson
Figure 7.3: Financial benchmarking of Johnson & Johnson against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Johnson & Johnson against Top five best
Figure 7.5: Global industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Johnson & Johnson (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.12: European market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.15: Johnson & Johnson productivity: 2007-2011 in (US $B)
Figure 7.16: Johnson & Johnson fixed asset value: 2007-2011 in (US $B)
Figure 7.17: Strategic execution
CHAPTER 8. Company Profile of 3M
Figure 8.1: 3M revenue by business structure 2011
Figure 8.2: Lucintel triad – 3M
Figure 8.3: Financial benchmarking of 3M against top three and top five industry players